3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Leukemia, Myeloid, Acute
19
Leukemia
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Myelodysplastic Syndromes
14
Lymphoma
11
Multiple Myeloma
10
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10
Leukemia, Lymphocytic, Chronic, B-Cell
7
Lymphoma, Non-Hodgkin
6
Leukemia, Biphenotypic, Acute
5
Hodgkin Disease
5
Neuroblastoma
4
Hematologic Neoplasms
4
Hematologic Diseases
4
Sarcoma, Ewing
3
Rhabdomyosarcoma
3
Neoplasms, Plasma Cell
3
Lymphoma, Follicular
3
Graft vs Host Disease
3
Congenital Abnormalities
3
Burkitt Lymphoma
3
Brain Neoplasms
3
Wilms Tumor
2
Waldenstrom Macroglobulinemia
2
Testicular Neoplasms
2
Sarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Myeloproliferative Disorders
2
Medulloblastoma
2
Lymphoma, T-Cell, Cutaneous
2
Interventions
Ifosfamide
30
Methotrexate
27
Doxorubicin
25
Cyclophosphamide
24
Cisplatin
22
Filgrastim
18
Etoposide
17
Gemcitabine
16
Leucovorin
14
Magnetic Resonance Spectroscopy
11
Temozolomide
10
cabozantinib
9
apatinib
9
Specimen Handling
9
Carboplatin
9
fludarabine
8
X-Rays
8
Nivolumab
8
Neoadjuvant Therapy
8
Irinotecan
8
Granulocyte Colony-Stimulating Factor
8
Docetaxel
8
Zoledronic Acid
7
Vincristine
7
Sirolimus
7
Radiotherapy
7
Phantoms, Imaging
7
Biopsy
7
Topotecan
6
Mesna
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Osteosarcoma
×
Bone Marrow Transplantation
×
Clear all
NCT02100891
2025-03-19
STIR
Medical College of Wisconsin
Phase 2
Terminated
15 enrolled
11 charts